The Human Papillomavirus (HPV) Pipeline Market Review, H1 2017, provides an overview of the Human Papillomavirus E6 Protein Pipeline landscape. The Human Papillomavirus (HPV) Pipeline E6 Protein Market Report provide reviews for key companies involved in Human Papillomavirus (HPV) E6 protein therapeutics development and enlists all their major and minor projects.
Human Papillomavirus Protein E6 (E6) - The Human Papillomavirus (HPV) E6 protein is one of oncoproteins encoded by the virus. It is a 151 amino-acid peptide. It plays a major role in the induction and maintenance of cellular transformation. It acts mainly as an oncoprotein by stimulating the destruction of many host cell key regulatory proteins. The complex E6/E6P targets several other substrates to degradation via the proteasome including host NFX1-91. The resulting increased expression of hTERT prevents the shortening of telomere length leading to cell immortalization.
The latest report Human Papillomavirus Protein E6 (E6) - Pipeline Review, H1 2017, outlays comprehensive information on the Human Papillomavirus Protein E6 (E6) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Human Papillomavirus Protein E6 (E6) targeted therapeutics development with respective active and dormant or discontinued projects.
Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1020000 .
The Key Company Profiles are Abion Inc, BioNTech AG, Cancer Research Technology Ltd, Etubics Corp, Genexine Inc, Hookipa Biotech AG, Inovio Pharmaceuticals Inc, MedImmune LLC, Rottapharm Biotech Srl, Selecta Biosciences Inc, Tomegavax Inc, and Transgene SA.
The latest Pharmaceutical and Healthcare disease pipeline guide Human Papillomavirus Protein E6 (E6) - Pipeline Review, H1 2017, provides an overview of the Human Papillomavirus Protein E6 Protein Pipeline landscape.
Human Papillomavirus Vaccine - Drug Profile
INO-3106 - Drug Profile, MEDI-0457 - Drug Profile.
Vaccine to Target HPV E6 for Cervical Intraepithelial Neoplasia - Drug Profile
VGX-3100 - Drug Profile, Vvax-001 - Drug Profile.
The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1020000
Human Papillomavirus Protein E6 (E6) pipeline Target constitutes close to 24 molecules. Out of which approximately 17 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 2, 9 and 1 respectively. Similarly, the universities portfolio in Phase II, Preclinical and Discovery stages comprises 2, 3 and 2 molecules, respectively. Report covers products from therapy areas Oncology, Women's Health and Infectious Disease which include indications Human Papillomavirus (HPV) Associated Cancer, Cervical Cancer, Head and Neck Cancer Squamous Cell Carcinoma, Cervical Intraepithelial Neoplasia (CIN), Head and Neck Cancer, Human Papillomavirus Infections and Lung Cancer.
Scope
The report provides a snapshot of the global therapeutic landscape for Human Papillomavirus Protein E6 (E6)
The report reviews Human Papillomavirus Protein E6 (E6) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in Human Papillomavirus Protein E6 (E6) targeted therapeutics and enlists all their major and minor projects
The report assesses Human Papillomavirus Protein E6 (E6) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
The report reviews latest news and deals related to Human Papillomavirus Protein E6 (E6) targeted therapeutics
Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1020000 .
Table of Contents:
Human Papillomavirus E6 Protein Pipeline- Overview
Human Papillomavirus E6 Protein Pipeline - Therapeutics Development
Human Papillomavirus E6 Protein Pipeline Overview
Human Papillomavirus E6 Protein Pipeline by Companies
Human Papillomavirus E6 Protein Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Human Papillomavirus E6 Protein Pipeline - Therapeutics Assessment
Human Papillomavirus E6 Protein Pipeline - Companies Involved in Therapeutics Development
Human Papillomavirus E6 Protein Pipeline - Drug Profiles
Human Papillomavirus E6 Protein Pipeline - Dormant Projects
Human Papillomavirus E6 Protein Pipeline - Product Development Milestones

List of Tables.
Number of Products under Development for Human Papillomavirus E6 Protein Pipeline,
Products under Development by Companies, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Human Papillomavirus E6 Protein Pipeline - Pipeline by Abion Inc,
Human Papillomavirus E6 Protein Pipeline - Pipeline by BioNTech AG,
Human Papillomavirus E6 Protein Pipeline - Pipeline by Cancer Research Technology Ltd,
Human Papillomavirus E6 Protein Pipeline - Pipeline by Etubics Corp,
Human Papillomavirus E6 Protein Pipeline - Pipeline by Genexine Inc,
Human Papillomavirus E6 Protein Pipeline - Pipeline by Inovio Pharmaceuticals Inc,
Human Papillomavirus E6 Protein Pipeline - Dormant Projects, H1 2017
Human Papillomavirus E6 Protein Pipeline - Discontinued Products, H1 2017

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on [email protected] with your contact details.